Your browser doesn't support javascript.
loading
SREBF1c and SREBF2 gene polymorphisms are associated with acute coronary syndrome and blood lipid levels in Mexican population.
Vargas-Alarcon, Gilberto; Gonzalez-Pacheco, Hector; Perez-Mendez, Oscar; Posadas-Sanchez, Rosalinda; Cardoso-Saldaña, Guillermo; Ramirez-Bello, Julian; Escobedo, Galileo; Nieto-Lima, Betzabe; Fragoso, Jose Manuel.
Afiliação
  • Vargas-Alarcon G; Department of Molecular Biology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
  • Gonzalez-Pacheco H; Atherosclerosis Study Group, Instituto Nacional de Cardiología Ignacio Chavez, Mexico City, Mexico.
  • Perez-Mendez O; Atherosclerosis Study Group, Instituto Nacional de Cardiología Ignacio Chavez, Mexico City, Mexico.
  • Posadas-Sanchez R; Coronary Unit, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
  • Cardoso-Saldaña G; Department of Molecular Biology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
  • Ramirez-Bello J; Atherosclerosis Study Group, Instituto Nacional de Cardiología Ignacio Chavez, Mexico City, Mexico.
  • Escobedo G; Department of Endocrinology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
  • Nieto-Lima B; Department of Endocrinology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
  • Fragoso JM; Research Unit on Endocrine and Metabolic Diseases, Hospital Juarez de Mexico, Mexico City, Mexico.
PLoS One ; 14(9): e0222017, 2019.
Article em En | MEDLINE | ID: mdl-31490983
AIM: It has recently been reported that the sterol regulatory element-binding transcription factors (SREBF-1c, and -2) contribute to the variation in the plasma lipids levels, which have an important role in the atherosclerotic plaque development. The aim of the present study was to evaluate whether the SREBF1c and SREBF2 gene single nucleotide polymorphisms (SNPs) are associated with plasma lipids levels and ACS susceptibility in a case-control association study. MATERIAL AND METHODS: A case-control study was carried out in 625 patients with ACS (82% men and 18% women, with a mean age of 57.97 ± 10.5 years) and 700 healthy controls (66% men and 34% women, with a mean age of 54.37 ± 7.65 years). The sample size was calculated for a statistical power of 80%. We genotyped three SREBF1c (rs2297508, rs11656665 and rs11868035) and three SREBF2 (rs2267439, rs2267443, and rs2228314) gene polymorphisms by 5' exonuclease TaqMan assays. The associations were evaluated by logistic regression under the co-dominant, dominant, recessive, over-dominant and additive inheritance models. The contribution of the genotypes on the plasma lipids levels was evaluated by Student's t-test. RESULTS: Under different models, the SREBF1c rs2297508 (OR = 1.50, pCRes = 0.03), SREBF1c rs11656665 (OR = 1.35, pCDom = 0.02 and OR = 1.26, pCAdd = 0.02) and SREBF2 rs2228314 (OR = 1.78, pCRes = 0.03, OR = 1.27, pCAdd = 0.04) SNPs were associated with higher risk of ACS. On the other hand, the SREBF1c rs11868035 SNP was associated with lower risk of ACS (OR = 0.49, pCCo-dom = 0.001, OR = 0.66, pCDom = 0.003, OR = 0.57, PRes = 0.003 and OR = 0.71, pCAdd = 0.001). There was a statistically significant association of both SREBF1c rs11656665 and rs11868035 polymorphisms with plasma triglyceride levels. CONCLUSIONS: In summary, our data suggest the association of the SREBF1c and SREBF2 SNPs with risk of developing ACS and with triglyceride levels in a Mexican population.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo de Nucleotídeo Único / Proteína de Ligação a Elemento Regulador de Esterol 1 / Proteína de Ligação a Elemento Regulador de Esterol 2 / Síndrome Coronariana Aguda / Lipídeos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo de Nucleotídeo Único / Proteína de Ligação a Elemento Regulador de Esterol 1 / Proteína de Ligação a Elemento Regulador de Esterol 2 / Síndrome Coronariana Aguda / Lipídeos Idioma: En Ano de publicação: 2019 Tipo de documento: Article